Kelowna, British Columbia – November 5, 2020 – Citation Growth Corp. (CSE:CGRO) (OTCQX:CGOTF) (“Citation” or the “Company”), a licensed multi-state cannabis cultivator, producer and retailer, announces that pursuant to a Director’s Resolution, it will change its name to Fiore Cannabis Ltd. and trade under the ticker symbol “FIOR” on the Canadian Securities Exchange (the “CSE”). The CSE will publish a bulletin announcing the effective date of the change and it is anticipated that the common shares will begin trading under the new name on or about Tuesday November 10, 2020. The CUSIP number assigned to the Company’s common shares following the name change is 31811L107 (ISIN CA31811L1076). The Company’s listed common share purchase warrants, expiring January 31, 2021, will begin trading on the CSE under the new trading symbol “FIOR.WT” with the new CUSIP 31811L115 (ISIN CA31811L1159).
Erik Anderson, CEO of Fiore, stated: “As the company continues to make great strides in our efforts to evolve the company in line with our vision of ‘moving forward,’ management and the Board of Directors felt it was prudent to update our corporate identity in relation to our strong branding in the Nevada market. Fiore is an award-winning flower and the crown jewel of the corporation. Our proprietary cultivation methodologies at our North Las Vegas Apex facility maximize the potential for our unique genetic library of organic cannabis strains and produce a retail product that garners a market premium. Being a premium organic producer in one of the biggest markets in the U.S. positions Fiore well for growth into 2021 and beyond. We have installed full spectrum LED lighting from Fluence in the facility and are eagerly looking forward to increasing supply of a highly sought-after product in the Nevada market.”
No action is required to be taken by shareholders with respect to the name change. Outstanding share and warrant certificates are not affected by the name change and do not need to be exchanged.
About Citation Growth Corp.
Citation Growth Corp. (CSE:CGRO) (OTCQX:CGOTF) is a publicly traded company that has been investing in the development of medical and recreational cannabis products since 2014. Citation has expanded its operating portfolio to include cultivation, production and retail offerings in our key North American legal jurisdictions Nevada, California, Washington and British Columbia. For more information, please visit www.citationgrowth.com.
For Further Information
Erik Anderson, President and CEO
1-877-438-5448 Ext. 713
Cannabis Industry Involvement
The Company owns marijuana licenses in California and Nevada. Marijuana is legal in each state; however, marijuana remains illegal under United States federal law and the approach to enforcement of U.S. federal law against marijuana is subject to change. Shareholders and investors need to be aware that federal enforcement actions could adversely affect their investments and that the Company’s ability to support continuing U.S.-based operations and its access private and public capital could be materially adversely affected.
This news release contains forward-looking statements or information that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the future business strategy; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; changes in laws and regulations; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.